-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Agile Therapeutics Inc quarterly/annual Selling and Marketing Expense history and growth rate from 2018 to 2023.
- Agile Therapeutics Inc Selling and Marketing Expense for the quarter ending June 30, 2024 was $3.78M, a 17.4% decline year-over-year.
- Agile Therapeutics Inc Selling and Marketing Expense for the twelve months ending June 30, 2024 was $16M, a 26.1% decline year-over-year.
- Agile Therapeutics Inc annual Selling and Marketing Expense for 2023 was $17.8M, a 41.5% decline from 2022.
- Agile Therapeutics Inc annual Selling and Marketing Expense for 2022 was $30.4M, a 30.1% decline from 2021.
- Agile Therapeutics Inc annual Selling and Marketing Expense for 2021 was $43.4M, a 86.6% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)